United Kingdom News Beep | NewsBeep.com
  • News Beep
  • United Kingdom
  • Headlines
  • Business
  • Entertainment
  • Health
  • Science
  • Sports
  • Technology
United Kingdom News Beep | NewsBeep.com
United Kingdom News Beep | NewsBeep.com
  • News Beep
  • United Kingdom
  • Headlines
  • Business
  • Entertainment
  • Health
  • Science
  • Sports
  • Technology

Browsing Tag

Novo Nordisk

89 posts
MMedication
#EASD26: Regeneron’s antibody helps patients regain muscle after stopping GLP-1 therapy - Endpoints News
Read More

#EASD26: Regeneron’s antibody helps patients regain muscle after stopping GLP-1 therapy – Endpoints News

  • October 1, 2026
#EASD26: Regeneron’s antibody helps patients regain muscle after stopping GLP-1 therapy  Endpoints NewsRegeneron weight-loss drug halves muscle loss in…
MMedication
Novo receives Singapore approval for Wegovy® as first treatment for MASH with liver fibrosis
Read More

Novo receives Singapore approval for Wegovy® as first treatment for MASH with liver fibrosis

  • September 25, 2026
ESSENCE trial data showed 63% of participants receiving semaglutide achieved steatohepatitis resolution without worsening of liver fibrosis, compared…
MMedication
Hundreds of lawsuits filed against some GLP-1 Makers over vision loss
Read More

Hundreds of lawsuits filed against some GLP-1 Makers over vision loss

  • September 22, 2026
Hundreds of Americans are suing GLP-1 drugmakers Novo Nordisk and Ely Lilly, saying they were not adequately warned…
MMedication
Novo Sets Long-Term Targets Ahead of Semaglutide Patent Expirations - Yahoo Finance
Read More

Novo Sets Long-Term Targets Ahead of Semaglutide Patent Expirations – Yahoo Finance

  • September 21, 2026
Novo Sets Long-Term Targets Ahead of Semaglutide Patent Expirations  Yahoo FinanceNovo shares slide as drugmaker lays out post-Wegovy growth…
EEconomy
Novo cuts 13,000 jobs in a year – The Irish Times
Read More

Novo cuts 13,000 jobs in a year – The Irish Times

  • September 21, 2026
Novo said on Monday it had cut its workforce by 13,000 in the past year as the maker…
MMedication
The Semaglutide Cliff vs. a 10x Multiple: Is Novo Nordisk (NVO) a Value Trap or a Bargain?
Read More

The Semaglutide Cliff vs. a 10x Multiple: Is Novo Nordisk (NVO) a Value Trap or a Bargain?

  • September 21, 2026
Morgan Stanley has cut Novo Nordisk A/S (NYSE:NVO) to Underweight on September 11, 2026. Semaglutide, the underlying molecule…
HHealthcare
Novo Nordisk enters next chapter to bring better health to more people, supported by ‘Novo’ rebrand and updated corporate culture
Read More

Novo Nordisk enters next chapter to bring better health to more people, supported by ‘Novo’ rebrand and updated corporate culture

  • September 19, 2026
Novo Nordisk A/S Bagsværd, Denmark, 14 September 2026 – Novo Nordisk marked the beginning of its next chapter…
HHealthcare
Eli Lilly’s (LLY) Growth Story Keeps Adding Chapters
Read More

Eli Lilly’s (LLY) Growth Story Keeps Adding Chapters

  • August 18, 2026
On August 5, Eli Lilly (NYSE:LLY) told investors its second quarter delivered 48% revenue growth, and the days…
MMedication
Sun Pharma Requires High Court Approval for Semaglutide Tablet Launch Amid Patent Dispute, ETPharma
Read More

Sun Pharma Requires High Court Approval for Semaglutide Tablet Launch Amid Patent Dispute, ETPharma

  • August 12, 2026
New Delhi: The Delhi High Court on Tuesday asked Sun Pharma Laboratories to take its prior approval before…
MMedication
The Future of Finance? Google Is Bringing Betting Odds Directly To Your Screen, Sparking Calls For 'Addiction Warnings'
Read More

Amazon Is Bringing the Weight-Loss Drug Race to Medicare

  • August 8, 2026
This article first appeared on GuruFocus. Amazon.com Inc. (AMZN, Financials), the e-commerce and cloud-computing company, is expanding its…
MMedication
A recent high-profile court judgment halting a Pretoria pharmacy from selling GLP-1 drugs at scale has seemingly done little to stem the tide of a growing illicit industry.
Read More

Hairdressers selling ‘Ozempic’: SA’s wild weight loss market

  • August 2, 2026
A recent high-profile court judgment halting a Pretoria pharmacy from selling GLP-1 drugs at scale has seemingly done…
BBusiness
Novo Nordisk provides update on the ZEUS phase 3 trial in people with ASCVD, CKD and inflammation
Read More

Novo Nordisk provides update on the ZEUS phase 3 trial in people with ASCVD, CKD and inflammation

  • August 1, 2026
Novo Nordisk A/S Bagsværd, Denmark, 31 July 2026 – Novo Nordisk today announced headline results from the ZEUS cardiovascular…
United Kingdom News Beep | NewsBeep.com
www.newsbeep.com